Source:http://linkedlifedata.com/resource/pubmed/id/12490280
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-12-19
|
pubmed:abstractText |
Protein Z was recently shown to act as an essential cofactor for protein Z-dependent protease inhibitor, a potent downregulator of coagulation Factor Xa. Thus, deficiency of protein Z is hypothesized to lead to a prothrombotic state, but two publications reported opposing results for the relationship of protein Z levels with ischemic stroke in young European subjects (mean age 33-40 years). We performed a study of stroke in a different ethnic population of greater mean age (57 years) to further clarify this issue. An ELISA was developed to measure protein Z antigen in 154 patients with ischemic stroke and in 206 controls in a largely Hispanic population. Low plasma protein Z values were significantly associated with ischemic stroke except in diabetic subjects and females. The mean protein Z value was significantly lower in stroke cases than in controls for nondiabetic subjects [1.78 +/- 0.77 (S.D.) versus 2.28 +/- 0.88 microg/ml, P < 0.0001] and for males (1.90 +/- 0.90 versus 2.42 +/- 0.99 microg/ml, P = 0.0004). Stroke risk was higher in subjects with protein Z levels at or below the fifteenth percentile of controls (</=1.46 microg/ml). The odds ratios were: 2.6 for all subjects (95% C.I. = 1.5-4.3); 3.8 for nondiabetic subjects (95% C.I. = 2.2-6.8); and 3.6 for males (95% C.I. = 2.0-6.4). This study also revealed high protein Z levels associated with high triglyceride levels in controls (P = 0.015). Protein Z is suggested to be a physiologic downregulator of blood coagulation and low protein Z levels are associated with increased risk of ischemic stroke, particularly in males and in the absence of diabetes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1079-9796
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-44
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12490280-Adult,
pubmed-meshheading:12490280-Aged,
pubmed-meshheading:12490280-Aged, 80 and over,
pubmed-meshheading:12490280-Blood Proteins,
pubmed-meshheading:12490280-Case-Control Studies,
pubmed-meshheading:12490280-Diabetes Complications,
pubmed-meshheading:12490280-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12490280-Female,
pubmed-meshheading:12490280-Hispanic Americans,
pubmed-meshheading:12490280-Humans,
pubmed-meshheading:12490280-Ischemia,
pubmed-meshheading:12490280-Male,
pubmed-meshheading:12490280-Middle Aged,
pubmed-meshheading:12490280-Risk Factors,
pubmed-meshheading:12490280-Sex Factors,
pubmed-meshheading:12490280-Stroke,
pubmed-meshheading:12490280-United States
|
pubmed:articleTitle |
Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender.
|
pubmed:affiliation |
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. heeb@scripps.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|